← All trials
NCT03975387
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 15, 2019
- Primary completion
- Apr 22, 2023
- Completion date
- May 27, 2023
- First posted
- —
- Last posted
- —
- Enrollment
- 135
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Astex Pharmaceuticals, Inc.Lead sponsor
- Astex Pharmaceuticals, Inc.Study director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.